{
    "64403ab057b1c7a31500004d_001": "two",
    "6411b678201352f04a000036_001": "acquired",
    "6411b678201352f04a000036_002": "autosomal dominant",
    "6411b678201352f04a000036_003": "acquired",
    "643bc8f957b1c7a31500002b_001": "A promoter is a short region of DNA (100-1,000 bp) where transcription of a gene by RNA polymerase begins.",
    "643bc8f957b1c7a31500002b_002": "Promoters",
    "64403be357b1c7a31500004e_001": "24 weeks",
    "6440396957b1c7a31500004b_001": "Suprachoroidal",
    "6440396957b1c7a31500004b_002": "Suprachoroidal",
    "6431708a57b1c7a315000017_001": "T1AM",
    "6431708a57b1c7a315000017_002": "miR-145",
    "6431708a57b1c7a315000017_003": "cardiomyocytes",
    "640f8641201352f04a00002c_001": "trabeculotomy",
    "640f8641201352f04a00002c_002": "P",
    "640f8641201352f04a00002c_003": "3 Schlemm's Canal Microinvasive Glaucoma Surgery Devices.",
    "640f8641201352f04a00002c_004": "eyes",
    "640f8641201352f04a00002c_005": "subscleral",
    "644009c557b1c7a315000041_001": "autosomal recessive",
    "64371a4257b1c7a315000029_001": "operons",
    "64371a4257b1c7a315000029_002": "operons",
    "64371a4257b1c7a315000029_003": "Clustering of functionally related genes in operons",
    "6440377c57b1c7a315000049_001": "triamcinolone acetonide",
    "6441057657b1c7a315000052_001": "FLACC",
    "6441057657b1c7a315000052_002": "FLACC and COMFORT",
    "6441057657b1c7a315000052_003": "Wong-Baker Faces Pain Rating Scale",
    "6441057657b1c7a315000052_004": "FLACC-r",
    "6441057657b1c7a315000052_005": "FLACC",
    "64257c9c690f196b5100004b_001": "drug-specific liver injury phenotypes",
    "64257c9c690f196b5100004b_002": "phenotype-based drug-induced liver injury causality assessment tool",
    "64257c9c690f196b5100004b_003": "early detection of drug's hepatotoxicity in clinical drug development",
    "6429e85e57b1c7a315000009_001": "riboswitches",
    "6429e85e57b1c7a315000009_002": "riboswitches are typically located in noncoding regions of mRNA,",
    "6429e85e57b1c7a315000009_003": "Metabolite-sensing mRNAs, or \"riboswitches,",
    "6429e85e57b1c7a315000009_004": "Riboswitches",
    "6440393157b1c7a31500004a_001": "2021",
    "6415b3b4690f196b51000009_001": "yellow light",
    "6429fad757b1c7a31500000e_001": "TATA\" box",
    "6429fad757b1c7a31500000e_002": "TATAWAWR",
    "6429fad757b1c7a31500000e_003": "TATA box",
    "6429fad757b1c7a31500000e_004": "TATA box",
    "64402e7757b1c7a315000044_001": "9",
    "64402e7757b1c7a315000044_002": "Nineteen",
    "64425ce357b1c7a315000059_001": "1:8000",
    "64425ce357b1c7a315000059_002": "1 in 20000",
    "63f581e933942b094c000007_001": "spinal muscular atrophy",
    "63f581e933942b094c000007_002": "spinal muscular atrophy",
    "63f581e933942b094c000007_003": "spinal muscular atrophy",
    "63f581e933942b094c000007_004": "SMA",
    "6431f7de57b1c7a31500001b_001": "frataxin",
    "6431f7de57b1c7a31500001b_002": "frataxin",
    "6431f7de57b1c7a31500001b_003": "frataxin",
    "6431f7de57b1c7a31500001b_004": "Frataxin",
    "6431f7de57b1c7a31500001b_005": "frataxin",
    "6431f7de57b1c7a31500001b_006": "frataxin",
    "6431f7de57b1c7a31500001b_007": "frataxin",
    "643f9eeb57b1c7a31500003c_001": "1:5,000 live male births",
    "643f9eeb57b1c7a31500003c_002": "19.7",
    "6415c252690f196b51000011_001": "Cancer",
    "6415c252690f196b51000011_002": "bladder cancer",
    "63eeed0af36125a426000007_001": "Multiple Myeloma",
    "63eeed0af36125a426000007_002": "multiple myeloma",
    "63eeed0af36125a426000007_003": "multiple myeloma",
    "63eeed0af36125a426000007_004": "Multiple Myeloma",
    "63eeed0af36125a426000007_005": "multiple myeloma",
    "63f03ea0f36125a426000020_001": "rCDI",
    "63f03ea0f36125a426000020_002": "Clostridioides difficile",
    "63f03ea0f36125a426000020_003": "C. difficile",
    "63f03ea0f36125a426000020_004": "Clostridioides difficile",
    "64179113690f196b5100002e_001": "Xp21 chromosome locus",
    "64179113690f196b5100002e_002": "Xp21",
    "64179113690f196b5100002e_003": "Xp21",
    "6415c9e9690f196b51000018_001": "mTNBC"
}
